Navigation Links
Defying Industry Trends, BBK Worldwide Expands Ownership From Within

NEWTON, Mass., March 21, 2013 /PRNewswire/ -- In an industry increasingly defined by mergers and acquisitions, BBK Worldwide (BBK) is bucking the trend by creating ownership opportunities from within. Celebrating 30 years, BBK remains one of the only independent and self-funded patient recruitment agencies, and is able to offer its global pharmaceutical and medical device clients levels of flexibility and creative innovation unmatched by its competitors. This history of vision and leadership has led BBK to name four additional principals who, together, will assume a minority ownership in the company. All long-serving employees, Matthew Kibby , Rob Laurens , Liz Ritchie , and Matthew Stumm have played key roles in shaping the company's success as the global leader in patient recruitment for the clinical R&D segment of the pharma, biotech, and medical device industries. As principals, they will partner with BBK's founding principals Joan F. Bachenheimer and Bonnie A. Brescia to maintain the company's core mission and values while driving growth in key market areas.

"These four individuals have made unyielding contributions to BBK over the years -- contributions that have brought innovation and definition to the patient recruitment marketplace as a whole," comments Joan F. Bachenheimer , founding principal, BBK Worldwide. "Their new roles will allow for expanded growth in critical business areas, ensuring that current and future customers benefit from the most strategic and sophisticated thinking in the industry."

Each newly named principal will focus their efforts on expanding their current management areas. Matthew Stumm will draw upon his creative vision to drive innovation for Agency320, BBK's partner company responsible for creative and media services. Rob Laurens will apply his 19 years of industry knowledge to advance patient recruitment training and industry best practices. Liz Ritchie , BBK's third longest-serving employee, will continue to manage corporate and legal services. Matthew Kibby will apply his innovative mindset to expanding and refining product offerings from BBK's technology partner TCN Technologies and its hallmark product TrialCentralNetSM.

Companies often turn to mergers and acquisitions as a corporate strategy for creating growth, however, often at the expense of innovation. BBK's current move represents a deliberate shift from this industry trend. "Over the past 10 years, BBK has been approached by several different organizations interested in taking an outside investment in BBK," comments Bonnie A. Brescia , founding principal, BBK Worldwide. "We've taken a different approach that values the commitment and dedication of our employees. Our business model reflects our commitment to, and appreciation for, our employees and for their hard work and investment. This dynamic model creates opportunities to expand ownership from within."

Guided by the law firm of Morse, Barnes-Brown & Pendleton, PC, BBK was able to create a new corporate structure that also has the potential to seamlessly expand ownership opportunities to other deserved employees within the company -- further ensuring the retention of key talent and the viability of the company moving forward. "We're thrilled to be able to connect employees to the success of the company with this new model that provides customers with the most experienced and sophisticated patient recruitment support in the industry," comments Bachenheimer.

The corporate restructure adds to the company's milestones of innovation, which include the first-ever web-based patient recruitment management system; the harnessing of the power of the Apple® iPad® to create a series of Study e-BinderSM clinical trial support products; and, most recently, the incorporation of social media techniques to promote clinical trials and to envelop the public in a better understanding of disease management and available options for treatment. Visit for more details on clinical trial innovation spearheaded by BBK Worldwide.

About BBK Worldwide (
Founded in 1983, BBK Worldwide is the recognized global leader in patient recruitment. The company is renowned for accelerating time to market for new and improved medicines and treatments. Through its partner companies, TCN Technologies and Agency320, BBK offers the industry the most sophisticated technology, creative, and media services. BBK meets WBENC accreditation standards and is certified as a Safe Harbor company.

SOURCE BBK Worldwide
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global Food Safety Testing Industry
2. Lucintel's Analysis of Global Catalysts Industry: Chemical and Automobile Industries Play Crucial Role in Growth
3. PwCs Health Research Institute Finds Shortage of Health IT Workers Could Slow Industry Progress
4. Rigaku Raman Unveils Upgraded FirstGuard Handheld Analyzer with Industry’s Only 1064nm Wavelength Capabilities
5. Global Implantable Drug Delivery Devices Market - New Industry Research Report Published by Transparency Market Research
6. SPIE co-sponsors ICTP Winter College on lasers for science, medicine, and industry
7. Food Micro-Fifth Edition: Microbiology Testing in the US Food Industry
8. Global Acrylonitrile Butadiene Styrene Market (ABS) - New Industry Research Report Published by Transparency Market Research
9. ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
10. Percival Scientific, Inc. Introduces an Affordable LED Lighting System for the Research Industry
11. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
Post Your Comments:
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
(Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
Breaking Biology Technology:
(Date:11/18/2015)... -- As new scientific discoveries deepen our understanding of how ... face challenges in better using that knowledge to guide ... more children continue to survive pediatric cancer, that counseling ... John M. Maris, M.D ., a pediatric ... . --> John M. Maris, M.D ...
(Date:11/17/2015)... LIVERMORE, Calif. , Nov. 17, 2015  Vigilant ... has joined its Board of Directors. ... Vigilant,s Board after recently retiring from the partnership at ... owning 107 companies with over $140 Billion in revenue.  ... performance improvement across all the TPG companies, from 1997 ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
Breaking Biology News(10 mins):